Bactobolin | CAS#72615-20-4

MedKoo Cat#: 341067 | Name: Bactobolin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Bactobolin is a biochemical.

Chemical Structure

Bactobolin

CAS#72615-20-4

Theoretical Analysis

MedKoo Cat#: 341067

Name: Bactobolin

CAS#: 72615-20-4

Chemical Formula: C14H20Cl2N2O6

Exact Mass: 382.0698

Molecular Weight: 383.22

Elemental Analysis: C, 43.88; H, 5.26; Cl, 18.50; N, 7.31; O, 25.05

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Bactobolin; Y 12278; Y-12278; Y12278.

IUPAC/Chemical Name

Propanamide, 2-amino-N-(3-(dichloromethyl)-3,4,4a,5,6,7-hexahydro-5,6,8-trihydroxy-3-methyl-1-oxo-1H-2-benzopyran-4-yl)-, (3S-(3alpha,4alpha(R*),4abeta,5beta,6a

InChi Key

RBCHRRIVFAIGFI-RGBMRXMBSA-N

InChi Code

InChI=1S/C14H20Cl2N2O6/c1-4(17)11(22)18-10-8-7(5(19)3-6(20)9(8)21)12(23)24-14(10,2)13(15)16/h4,6,8-10,13,19-21H,3,17H2,1-2H3,(H,18,22)/t4-,6+,8-,9-,10+,14-/m0/s1

SMILES Code

C1=2[C@H]([C@@H](NC(=O)[C@@H](N)C)[C@](OC1=O)(C(Cl)Cl)C)[C@@H](O)[C@@H](CC2O)O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 383.22 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Evans KC, Benomar S, Camuy-Vélez LA, Nasseri EB, Wang X, Neuenswander B, Chandler JR. Quorum-sensing control of antibiotic resistance stabilizes cooperation in Chromobacterium violaceum. ISME J. 2018 Jan 26. doi: 10.1038/s41396-018-0047-7. [Epub ahead of print] PubMed PMID: 29374267. 2: Wong RR, Kong C, Lee SH, Nathan S. Detection of Burkholderia pseudomallei toxin-mediated inhibition of protein synthesis using a Caenorhabditis elegans ugt-29 biosensor. Sci Rep. 2016 Jun 7;6:27475. doi: 10.1038/srep27475. PubMed PMID: 27273550; PubMed Central PMCID: PMC4895344. 3: Ojini I, Gammie A. Rapid Identification of Chemoresistance Mechanisms Using Yeast DNA Mismatch Repair Mutants. G3 (Bethesda). 2015 Jul 21;5(9):1925-35. doi: 10.1534/g3.115.020560. PubMed PMID: 26199284; PubMed Central PMCID: PMC4555229. 4: Amunts A, Fiedorczuk K, Truong TT, Chandler J, Peter Greenberg E, Ramakrishnan V. Bactobolin A binds to a site on the 70S ribosome distinct from previously seen antibiotics. J Mol Biol. 2015 Feb 27;427(4):753-5. doi: 10.1016/j.jmb.2014.12.018. Epub 2015 Jan 3. PubMed PMID: 25562208; PubMed Central PMCID: PMC4332689. 5: Chandler JR, Truong TT, Silva PM, Seyedsayamdost MR, Carr G, Radey M, Jacobs MA, Sims EH, Clardy J, Greenberg EP. Bactobolin resistance is conferred by mutations in the L2 ribosomal protein. MBio. 2012 Dec 18;3(6). pii: e00499-12. doi: 10.1128/mBio.00499-12. PubMed PMID: 23249812; PubMed Central PMCID: PMC3529544. 6: Chandler JR, Heilmann S, Mittler JE, Greenberg EP. Acyl-homoserine lactone-dependent eavesdropping promotes competition in a laboratory co-culture model. ISME J. 2012 Dec;6(12):2219-28. doi: 10.1038/ismej.2012.69. Epub 2012 Jul 5. PubMed PMID: 22763647; PubMed Central PMCID: PMC3504959. 7: Carr G, Seyedsayamdost MR, Chandler JR, Greenberg EP, Clardy J. Sources of diversity in bactobolin biosynthesis by Burkholderia thailandensis E264. Org Lett. 2011 Jun 17;13(12):3048-51. doi: 10.1021/ol200922s. Epub 2011 May 26. PubMed PMID: 21615115; PubMed Central PMCID: PMC3111747. 8: Seyedsayamdost MR, Chandler JR, Blodgett JA, Lima PS, Duerkop BA, Oinuma K, Greenberg EP, Clardy J. Quorum-sensing-regulated bactobolin production by Burkholderia thailandensis E264. Org Lett. 2010 Feb 19;12(4):716-9. doi: 10.1021/ol902751x. PubMed PMID: 20095633; PubMed Central PMCID: PMC2821070. 9: Adachi H, Nishimura Y. Synthesis and biological activity of bactobolin glucosides. Nat Prod Res. 2003 Aug;17(4):253-7. PubMed PMID: 12822903. 10: Adachi H, Nishimura Y, Takeuchi T. Synthesis and activities of bactobolin derivatives having new functionality at C-3. J Antibiot (Tokyo). 2002 Jan;55(1):92-8. PubMed PMID: 11918072. 11: Ishizuka M. [Action and molecular targets of anti cancer agents from microbial products]. Jpn J Antibiot. 1999 Feb;52(2):174-5. Japanese. PubMed PMID: 10221183. 12: Kawada M, Amemiya M, Ishizuka M, Takeuchi T. Differential induction of apoptosis in B16 melanoma and EL-4 lymphoma cells by cytostatin and bactobolin. Jpn J Cancer Res. 1999 Feb;90(2):219-25. PubMed PMID: 10189893. 13: Adachi H, Nishimura Y, Kondo S, Takeuchi T. Synthesis and activity of 3-epi-actinobolin. J Antibiot (Tokyo). 1998 Feb;51(2):202-9. PubMed PMID: 9544942. 14: Adachi H, Usui T, Nishimura Y, Kondo S, Ishizuka M, Takeuchi T. Synthesis and activities of bactobolin derivatives based on the alteration of the functionality at C-3 position. J Antibiot (Tokyo). 1998 Feb;51(2):184-8. PubMed PMID: 9544940. 15: Ishigaki Y, Sato T, Song DL, Hayashi K, Aoyagi T. Suppression of experimental autoimmune myasthenia gravis with new immunosuppressants: 15-deoxyspergualin and actinobolin. J Neurol Sci. 1992 Oct;112(1-2):209-15. PubMed PMID: 1469434. 16: Nishimura Y, Kondo S, Takeuchi T. Syntheses and activities of some bactobolin derivatives. J Antibiot (Tokyo). 1992 May;45(5):735-41. PubMed PMID: 1624375. 17: Ishizuka M. [Immunomodulation by antitumor antibiotics]. Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 2):697-700. Japanese. PubMed PMID: 3963840. 18: Umezawa H. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators]. Gan To Kagaku Ryoho. 1983 Apr;10(4 Pt 2):1071-86. Review. Japanese. PubMed PMID: 6191672. 19: Hori M, Suzukake K, Ishikawa C, Asakura H, Umezawa H. Biochemical studies on bactobolin in relation to actinobolin. J Antibiot (Tokyo). 1981 Apr;34(4):465-8. PubMed PMID: 7196909. 20: Munakata T, Okumoto T. Some structure-activity relationships for bactobolin analogs in the treatment of mouse leukemia P388. Chem Pharm Bull (Tokyo). 1981 Mar;29(3):891-4. PubMed PMID: 7249163.